These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 855730)

  • 21. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G; Keller C; Kilani C; Zöllner N
    Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
    [No Abstract]   [Full Text] [Related]  

  • 22. Family study of lipid and purine levels in gout patients and analysis of mortality.
    Darlington LG; Slack J; Scott JT
    Adv Exp Med Biol; 1980; 122A():21-6. PubMed ID: 7424637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of patients with gallstones with chenodeoxycholic acid (author's transl)].
    Leuschner U; Reber E; Erb W
    Dtsch Med Wochenschr; 1977 Feb; 102(5):156-60. PubMed ID: 832601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of chenodeoxycholic acid on cholesterol and triglyceride metabolism].
    Begemann F
    Z Gastroenterol Verh; 1976; (9):42-7. PubMed ID: 64084
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: More about chenodeoxycholic acid.
    Br Med J; 1973 Dec; 4(5893):629. PubMed ID: 4758539
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment.
    Pedersen L; Arnfred T; Thaysen EH
    Scand J Gastroenterol; 1974 Nov; 9(8):787-91. PubMed ID: 4610716
    [No Abstract]   [Full Text] [Related]  

  • 28. [Positive effects of chenodeoxycholic acid (CDCA) on the biohumoral clinical aspect of cholesterin calculosis of the gallbladder].
    Corazza GR; Simeone E; Di Giammarco AM; Ciccarelli R; Tenaglia G
    Minerva Med; 1978 Mar; 69(12):758-61. PubMed ID: 643217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dyslipoproteinaemia in primary gout].
    Mertz DP; Babucke G
    Dtsch Med Wochenschr; 1973 Aug; 98(31):1457-62. PubMed ID: 4718868
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gout and hyperlipemia].
    Günther R; Herbst M; Knapp E
    Wien Klin Wochenschr; 1967 Mar; 79(12):218-21. PubMed ID: 5585987
    [No Abstract]   [Full Text] [Related]  

  • 31. [Gout and hyperlipidemias (study on 50 gouty patients and 50 non gouty patients)].
    Rondier J; Truffert J; Le Go A; Brouilhet H; Saporta L; de Gennes JL; Delbarre F
    Rev Eur Etud Clin Biol; 1970 Nov; 15(9):959-68. PubMed ID: 5505086
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hyperlipidemia and bile acids].
    Yamamoto M; Kumagai A
    Nihon Rinsho; 1984 Jul; 42(7):1652-7. PubMed ID: 6492408
    [No Abstract]   [Full Text] [Related]  

  • 33. Can febuxostat reduce triglyceride and cholesterol serum levels in gouty patients?
    Saviola G; Benucci M; Abdi-Ali L; Sacco S; Cera I; Rossini M
    J Clin Rheumatol; 2014 Oct; 20(7):394-5. PubMed ID: 25275772
    [No Abstract]   [Full Text] [Related]  

  • 34. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
    Einarsson K; Hellström K; Leijd B
    J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid electrophoretic changes in the serum of patients with gout].
    Pristautz H; Klein G
    Z Rheumaforsch; 1972; 31(5):238-42. PubMed ID: 5048147
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of the conservative cholelitholytic therapy using chenodesoxycholic acid (CDC) on cholesterol and triglycerides in the blood of patients with gall stones].
    Caspary WF; Kattermann R
    Z Gastroenterol; 1975 Nov; 13(7):644-7. PubMed ID: 820098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia.
    Glueck CJ; Brown WV; Levy RI; Greten H; Fredrickson DS
    Lancet; 1969 Jun; 1(7609):1290-1. PubMed ID: 4182181
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial hyperuricaemia and hypertriglyceridaemia.
    Bennett RM; Chait A; Lewis B
    Ann Rheum Dis; 1973 Nov; 32(6):497-500. PubMed ID: 4760474
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lipid disorders in gout and in hyperuricemia with myalgia].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Mars Med; 1972; 109(10):609-25. PubMed ID: 4659841
    [No Abstract]   [Full Text] [Related]  

  • 40. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.